Essential Partners
BSX icon

Essential Partners’s Boston Scientific BSX Stock Holding History

Essential Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$208K Buy
4,772
+2,328
+95% +$108K 0.1% 232
2026
Q2 		$104K Buy
2,444
+1,428
+141% +$77.5K 0.05% 410
2026
Q1 		$63.8K Buy
1,016
+972
+2,209% +$77.8K 0.02% 538
2025
Q4 		$4.2K Sell
44
-5,204
-99% -$510K ﹤0.01% 1500
2025
Q3 		$512K Sell
5,248
-36
-0.7% -$3.73K 0.17% 171
2025
Q2 		$568K Buy
+5,284
New +$535K 0.23% 134

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
Gradient Investments
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Fisher Funds Management
Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Essential Partners's BSX Position: Q3 2026 in Review

Essential Partners increased its Boston Scientific (BSX) stake by 95% in Q3 2026, buying an estimated $108K and bringing the position to 4,772 shares worth $208K. The position accounts for 0.1% of the portfolio, ranked #232.

Essential Partners first reported a position in BSX in Q2 2025 and has held it in 6 quarters since. The position peaked at $568K in Q2 2025. 267 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Essential Partners held 4,772 shares of Boston Scientific worth $208K as of Q3 2026.
  • Essential Partners bought 2,328 Boston Scientific shares in Q3 2026, an estimated $108K.
  • Boston Scientific made up 0.1% of Essential Partners's portfolio in Q3 2026, its #232 holding.
  • Essential Partners first reported a position in Boston Scientific in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Boston Scientific position peaked at $568K in Q2 2025.
  • 267 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.